Valerio De Stefano Selected Research

factor V Leiden

10/2013	Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.
10/2013	Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups.
8/2013	Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
10/2012	Cerebral sinus-venous thrombosis.
3/2012	Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
1/2011	Causes of adult splanchnic vein thrombosis in the mediterranean area.
12/2010	Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
6/2008	The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
2/2008	Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
11/2006	The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valerio De Stefano Research Topics

Disease

37	Thrombosis (Thrombus) 01/2022 - 12/2002
21	Thrombophilia 01/2021 - 05/2002
18	Neoplasms (Cancer) 01/2022 - 06/2008
17	Venous Thromboembolism 10/2021 - 05/2002
16	Multiple Myeloma 10/2022 - 03/2006
16	Hemorrhage 01/2021 - 10/2004
15	Polycythemia Vera 12/2022 - 10/2002
14	Venous Thrombosis (Deep-Vein Thrombosis) 10/2022 - 12/2002
13	Essential Thrombocythemia 12/2022 - 10/2002
9	Primary Myelofibrosis (Myelosclerosis) 06/2022 - 02/2014
8	COVID-19 01/2022 - 10/2020
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 03/2007
5	Infections 01/2022 - 10/2012
4	Splenomegaly 04/2022 - 02/2017
4	Clinical Deterioration 01/2018 - 12/2010
4	Budd-Chiari Syndrome (Budd Chiari Syndrome) 12/2014 - 09/2012
4	Hyperhomocysteinemia 12/2014 - 10/2002
3	Thrombocytosis (Thrombocythemia) 04/2022 - 10/2002
3	Myocardial Infarction 04/2020 - 09/2004
3	Fibrosis (Cirrhosis) 01/2018 - 11/2014
3	Protein S Deficiency (Deficiency, Protein S) 03/2013 - 05/2002
2	Leukemia 06/2022 - 01/2017
2	Thrombocytopenia (Thrombopenia) 12/2021 - 01/2021
2	Atrial Fibrillation 10/2021 - 10/2004
2	Respiratory Insufficiency (Respiratory Failure) 10/2021 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2021 - 12/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2019 - 01/2015
2	Stroke (Strokes) 11/2018 - 03/2014
2	Liver Diseases (Liver Disease) 01/2018 - 06/2015
2	Pulmonary Embolism 01/2018 - 02/2015
2	Multiple Abnormalities 10/2013 - 06/2008
2	Wounds and Injuries (Trauma) 10/2012 - 01/2003
2	Upper Extremity Deep Vein Thrombosis 09/2012 - 06/2010
2	Acute Coronary Syndrome 03/2008 - 09/2004
1	Malnutrition (Nutritional Deficiencies) 08/2022
1	Leukocytosis (Pleocytosis) 04/2022
1	Dyspnea (Shortness of Breath) 04/2022
1	Lymphoma (Lymphomas) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Cerebral Hemorrhage 12/2021

Drug/Important Bio-Agent (IBA)

20	AnticoagulantsIBA 01/2022 - 10/2004
15	Prothrombin (Factor II)IBA 11/2014 - 05/2002
14	factor V LeidenIBA 10/2013 - 05/2002
11	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 05/2012
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 03/2007
10	ruxolitinibIBA 06/2022 - 02/2014
10	Protein CIBA 12/2013 - 05/2002
9	Vitamin K FDA Link 01/2022 - 03/2008
8	AntithrombinsIBA 10/2013 - 05/2002
7	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 04/2010
7	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021 - 10/2004
7	Protein SIBA 04/2014 - 10/2002
6	Oral ContraceptivesIBA 10/2012 - 01/2003
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
5	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 02/2003
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 11/2009
4	Lenalidomide (CC 5013)FDA Link 10/2022 - 06/2012
4	Inosine Triphosphate (ITP)IBA 01/2021 - 04/2010
3	daratumumabIBA 10/2022 - 05/2020
3	elotuzumabIBA 10/2022 - 01/2021
3	VaccinesIBA 12/2021 - 09/2021
3	Hemostatics (Antihemorrhagics)IBA 12/2021 - 11/2009
3	Thrombopoietin ReceptorsIBA 01/2021 - 06/2015
3	Biological ProductsIBA 01/2021 - 07/2006
3	Bortezomib (Velcade)FDA Link 01/2021 - 07/2012
3	Rituximab (Mabthera)FDA Link 01/2020 - 03/2007
3	Proteins (Proteins, Gene)FDA Link 02/2015 - 10/2012
3	Antiphospholipid AntibodiesIBA 01/2015 - 06/2008
2	InterferonsIBA 12/2022 - 09/2021
2	C-Reactive ProteinIBA 04/2022 - 10/2021
2	fibrin fragment D (D-dimer)IBA 04/2022 - 03/2016
2	mRNA VaccinesIBA 01/2022 - 09/2021
2	Proteasome InhibitorsIBA 01/2022 - 05/2020
2	COVID-19 VaccinesIBA 01/2021 - 01/2021
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 03/2008
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 03/2016
2	Prednisone (Sone)FDA LinkGeneric 02/2015 - 03/2006
2	Factor V (Coagulation Factor V)IBA 11/2014 - 10/2012
2	Thalidomide (Thalomid)FDA Link 07/2012 - 03/2006
2	Enoxaparin (Lovenox)FDA LinkGeneric 03/2006 - 10/2004
1	Urea (Carbamide)FDA LinkGeneric 04/2022
1	NitrogenIBA 04/2022
1	carfilzomibIBA 03/2022
1	ThromboxanesIBA 01/2022
1	RivaroxabanIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021
1	SodiumIBA 10/2021

Therapy/Procedure

25	Therapeutics 12/2022 - 12/2002
7	Drug Therapy (Chemotherapy) 04/2022 - 03/2006
4	Catheters 01/2016 - 06/2010
3	Hematopoietic Stem Cell Transplantation 08/2022 - 07/2012
3	Stem Cell Transplantation 01/2021 - 11/2016
2	Salvage Therapy 03/2022 - 01/2021
2	Liver Transplantation 01/2021 - 01/2018
2	Splenectomy 01/2021 - 02/2014
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2016 - 12/2010
1	Intravenous Administration 10/2022